Global Human Embryonic Stem Cells (Hescs) Market is anticipated to reach USD 1.06 billion by 2025, according to a new report by Grand View Research, Inc. Application of hESCs as a promising donor source for cellular transplantation therapies is anticipated to bolster progress through to 2025. hESCs technology tends to be useful for tissue engineering in humans due to high histocompatibility between host and graft.
Maintenance of developmental potential for contribution of derivatives of all three germ layers is an important feature of these cells. This ability remains consistent even after clonal derivation or prolonged undifferentiated proliferation, thus pronouncing its accelerated uptake.
In addition, these are capable in expressing high level of alkaline phosphatase, key transcription factors, and telomerase. These factors are found to be of great importance in the maintenance of the inner cellular mass pluripotency.
Furthermore, hESCs can be easily differentiated into defined neurons, neural lineages, oligodendrocytes, and astrocytes. Aforementioned characteristic makes it useful in studying the sequence of events that take place during early neurodevelopment.
However, use of stem cells derived from viable embryos is fraught with ethical issues, prompting scientists to explore other methods to generate ESCs. The other methods include derivation of embryonic germ cells, stem cells from dead embryos, and other techniques.
Full research report on Global Human Embryonic Stem Cells (hESC) Market: http://www.grandviewresearch.com/industry-analysis/human-embryonic-stem-cell-market
Further Key Findings from the Report Suggest:
View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the Global Human Embryonic Stem Cells Market on the basis of application and region:
Human Embryonic Stem Cells Application Outlook (Revenue, USD Million, 2014 – 2025)
Human Embryonic Stem Cells Regional Outlook (Revenue, USD Million, 2014 – 2025)
View Press Release on Global Human Embryonic Stem Cells (hESC) Market By Grand View Research: http://www.grandviewresearch.com/blog/bone-densitometers-market-size-share
About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more Information visit us: www.grandviewresearch.com
Media ContactCompany Name: Grand View Research, Inc.Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.Email: Send EmailPhone: 1-415-349-0058, Toll Free: 1-888-202-9519Address:28 2nd Street, Suite 3036 City: San FranciscoState: CaliforniaCountry: United StatesWebsite: http://www.grandviewresearch.com/industry-analysis/human-embryonic-stem-cell-market